CIK 0001434316
- Non-accelerated filer
- Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 651311552
- Phone
- +1 858-875-1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,525
- in 1 filing
Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-13 | Valamehr Bahram Chief Development Officer | Sale | −15,809 | $65.94 | $1.0M | 104,931 |
| 2021-09-13 | Valamehr Bahram Chief Development Officer | Sale | −8,391 | $66.84 | $561K | 96,540 |
| 2021-09-13 | Valamehr Bahram Chief Development Officer | Sale | −800 | $67.46 | $54K | 95,740 |
| 2021-09-13 | Valamehr Bahram Chief Development Officer | Option exercise · Stock Option (Right to Buy) | −25,000 | 86,156 | ||
| 2021-08-19 | Wolchko J Scott President and CEO | Option exercise | +20,000 | $4.84 | $97K | 413,793 |
| 2021-08-19 | Wolchko J Scott President and CEO | Sale | −20,000 | $88.01 | $1.8M | 393,793 |
| 2021-08-19 | Wolchko J Scott President and CEO | Option exercise · Stock Option (Right to Buy) | −20,000 | 4,846 | ||
| 2021-08-19 | Dulac Edward J III Chief Financial Officer | Sale | −1,937 | $87.90 | $170K | 56,076 |
| 2021-08-19 | Dulac Edward J III Chief Financial Officer | Sale | −1,474 | $88.65 | $131K | 54,602 |
| 2021-08-19 | Dulac Edward J III Chief Financial Officer | Sale | −63 | $90.00 | $6K | 54,539 |
| 2021-08-03 | Xu Yuan Director | Grant or award | +4,744 | 4,744 | ||
| 2021-08-03 | Xu Yuan Director | Grant or award · Stock Option (Right to Buy) | +7,501 | 7,501 | ||
| 2021-07-23 | Wolchko J Scott President and CEO | Option exercise | +10,000 | $2.73 | $27K | 403,793 |
| 2021-07-23 | Wolchko J Scott President and CEO | Option exercise | +20,000 | $4.84 | $97K | 423,793 |
| 2021-07-23 | Wolchko J Scott President and CEO | Sale | −30,000 | $85.28 | $2.6M | 393,793 |
| 2021-07-23 | Wolchko J Scott President and CEO | Option exercise · Stock Option (Right to Buy) | −10,000 | 90,000 | ||
| 2021-07-23 | Wolchko J Scott President and CEO | Option exercise · Stock Option (Right to Buy) | −20,000 | 24,846 | ||
| 2021-07-22 | Wolchko J Scott President and CEO | Option exercise | +30,000 | $2.73 | $82K | 423,793 |
| 2021-07-22 | Wolchko J Scott President and CEO | Sale | −6,627 | $85.38 | $566K | 417,166 |
| 2021-07-22 | Wolchko J Scott President and CEO | Sale | −21,773 | $86.19 | $1.9M | 395,393 |
Page 17 of 26 · 503 trades